Skip to main content

Peer Review reports

From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches

Original Submission
23 Aug 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Dec 2022 Reviewed Reviewer Report
27 Dec 2022 Reviewed Reviewer Report
8 Jan 2023 Author responded Author comments - Alaa Elmetwalli
Resubmission - Version 3
8 Jan 2023 Submitted Manuscript version 3
10 Jan 2023 Author responded Author comments - Alaa Elmetwalli
Resubmission - Version 4
10 Jan 2023 Submitted Manuscript version 4
12 Jan 2023 Reviewed Reviewer Report
27 Jan 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
3 Feb 2023 Editorially accepted
4 Mar 2023 Article published 10.1186/s12906-023-03872-6

You can find further information about peer review here.

Back to article page